Engineering memory T cells as a platform for long-term enzyme replacement therapy in lysosomal storage disorders

MLA

Kleinboehl, Evan W., et al. “Engineering Memory T Cells as a Platform for Long-Term Enzyme Replacement Therapy in Lysosomal Storage Disorders.” Molecular Therapy, vol. 32, no. 11, Nov. 2024, pp. 3865–78. EBSCOhost, https://doi.org/10.1016/j.ymthe.2024.09.033.

APA

Kleinboehl, E. W., Laoharawee, K., Jensen, J. D., Peterson, J. J., Slipek, N. J., Wick, B. J., Johnson, M. J., Webber, B. R., & Moriarity, B. S. (2024). Engineering memory T cells as a platform for long-term enzyme replacement therapy in lysosomal storage disorders. Molecular Therapy, 32(11), 3865–3878. https://doi.org/10.1016/j.ymthe.2024.09.033

Chicago

Kleinboehl, Evan W., Kanut Laoharawee, Jacob D. Jensen, Joseph J. Peterson, Nicholas J. Slipek, Bryce J. Wick, Matthew J. Johnson, Beau R. Webber, and Branden S. Moriarity. 2024. “Engineering Memory T Cells as a Platform for Long-Term Enzyme Replacement Therapy in Lysosomal Storage Disorders.” Molecular Therapy 32 (11): 3865–78. doi:10.1016/j.ymthe.2024.09.033.